Using the marker carbonic anhydrase 9 (CA9) (Wykoff et al, 2000), we found evidence of hypoxia in only 17% of the cutaneous deposits with an infiltrative growth compared with 71% of the tumours with an expansive, nodule-forming growth (P=0.02). The gene discussed is CA9; the disease is neoplasm.